טמיפלו - Tamiflu

טמיפלו - Tamiflu
התוויות	Treatment of influenza : Treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days. Prophylaxis of influenza : Post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older

ראו גם – הצטיידות בטמיפלו לקראת עונת השפעת 2013-2014

מידע ברשת

טמיפלו - Tamiflu


מרכיב פעיל	OSELTAMIVIR PHOSPHATE
קבוצה פרמקולוגית (ATC)	"NEURAMINIDASE INHIBITORS"
שם התרופה	"טמיפלו®" (קישור לדף התרופה במאגר משרד הבריאות)
סל הבריאות	לא כלול
התוויות	Treatment of influenza : Treatment of uncomplicated acute illness due to influenza infection in adults and children 1 year of age or older who have been symptomatic for no more than 2 days. Prophylaxis of influenza : Post exposure prevention in adults and children 1 year of age or older patients following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults and children 1 year of age or older
שם יצרן	HOFFMANN LA ROCHE LTD, SWITZERLAND
שם בעל הרישום	ROCHE PHARMACEUTICAL (ISRAEL) LTD
עלון לרופא	"עלון לרופא באנגלית"
עלון לצרכן	"עלון לצרכן בעברית"